Global Biologics and Biosimilars Market Research Report 2019 by Manufacturers, Regions, Types and Applications

Table of Contents

1 Report Overview

• 1.1 Definition
• 1.2 Manufacturers and Regions Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
• 1.3 Type Overview
• 1.4 Application Overview
• 1.5 Industrial Chain
  • 1.5.1 Biologics and Biosimilars Overall Industrial Chain
  • 1.5.2 Upstream
  • 1.5.3 Downstream
  • 1.5.4 Economic/Political Environment

2 Global Biologics and Biosimilars Market Assesment by Types

• 2.1 Overall Market Performance
  • 2.1.1 Product Type Market Performance (Volume)
  • 2.1.2 Product Type Market Performance (Value)
• 2.2 China Biologics and Biosimilars Market Performance
• 2.3 USA Biologics and Biosimilars Market Performance
• 2.4 Europe Biologics and Biosimilars Market Performance
• 2.5 Japan Biologics and Biosimilars Market Performance
• 2.6 Korea Biologics and Biosimilars Market Performance
• 2.7 India Biologics and Biosimilars Market Performance
• 2.8 Southeast Asia Biologics and Biosimilars Market Performance
• 2.9 South America Biologics and Biosimilars Market Performance

3 Global Biologics and Biosimilars Market Assesment by Application

• 3.1 Overall Market Performance (Volume)
• 3.2 China Biologics and Biosimilars Market Performance (Volume)
• 3.3 USA Biologics and Biosimilars Market Performance (Volume)
• 3.4 Europe Biologics and Biosimilars Market Performance (Volume)
• 3.5 Japan Biologics and Biosimilars Market Performance (Volume)
• 3.6 Korea Biologics and Biosimilars Market Performance (Volume)
• 3.7 India Biologics and Biosimilars Market Performance (Volume)
• 3.8 Southeast Asia Biologics and Biosimilars Market Performance (Volume)
• 3.9 South America Biologics and Biosimilars Market Performance (Volume)

4 Competitive Analysis

• 4.1 Pfizer
  • 4.1.1 Pfizer Profiles
  • 4.1.2 Pfizer Product Information
  • 4.1.3 Pfizer Biologics and Biosimilars Production, Revenue, Price and Gross Margin
  • 4.1.4 Pfizer Biologics and Biosimilars Business Performance
  • 4.1.5 SWOT Analysis
• 4.2 Roche
  • 4.2.1 Roche Profiles
  • 4.2.2 Roche Product Information
  • 4.2.3 Roche Biologics and Biosimilars Production, Revenue, Price and Gross Margin
  • 4.2.4 Roche Biologics and Biosimilars Business Performance
  • 4.2.5 SWOT Analysis
• 4.3 Amgen
  • 4.3.1 Amgen Profiles
  • 4.3.2 Amgen Product Information
  • 4.3.3 Amgen Biologics and Biosimilars Production, Revenue, Price and Gross Margin
  • 4.3.4 Amgen Biologics and Biosimilars Business Performance
  • 4.3.5 SWOT Analysis
• 4.4 AbbVie
  • 4.4.1 AbbVie Profiles
  • 4.4.2 AbbVie Product Information
  • 4.4.3 AbbVie Biologics and Biosimilars Production, Revenue, Price and Gross Margin
  • 4.4.4 AbbVie Biologics and Biosimilars Business Performance
  • 4.4.5 SWOT Analysis
• 4.5 Sanofi
  • 4.5.1 Sanofi Profiles
  • 4.5.2 Sanofi Product Information
  • 4.5.3 Sanofi Biologics and Biosimilars Production, Revenue, Price and Gross Margin
  • 4.5.4 Sanofi Biologics and Biosimilars Business Performance
  • 4.5.5 SWOT Analysis
• 4.6 Johnson & Johnson
  • 4.6.1 Johnson & Johnson Profiles
  • 4.6.2 Johnson & Johnson Product Information
  • 4.6.3 Johnson & Johnson Biologics and Biosimilars Production, Revenue, Price and Gross Margin
  • 4.6.4 Johnson & Johnson Biologics and Biosimilars Business Performance
  • 4.6.5 SWOT Analysis
• 4.7 Novo Nordisk
  • 4.7.1 Novo Nordisk Profiles
  • 4.7.2 Novo Nordisk Product Information
  • 4.7.3 Novo Nordisk Biologics and Biosimilars Production, Revenue, Price and Gross Margin
  • 4.7.4 Novo Nordisk Biologics and Biosimilars Business Performance
  • 4.7.5 SWOT Analysis
• 4.8 Novartis
  • 4.8.1 Novartis Profiles
  • 4.8.2 Novartis Product Information
  • 4.8.3 Novartis Biologics and Biosimilars Production, Revenue, Price and Gross Margin
  • 4.8.4 Novartis Biologics and Biosimilars Business Performance
  • 4.8.5 SWOT Analysis
• 4.9 Merck
  • 4.9.1 Merck Profiles
  • 4.9.2 Merck Product Information
  • 4.9.3 Merck Biologics and Biosimilars Production, Revenue, Price and Gross Margin
  • 4.9.4 Merck Biologics and Biosimilars Business Performance
  • 4.9.5 SWOT Analysis
• 4.10 Lilly
  • 4.10.1 Lilly Profiles
  • 4.10.2 Lilly Product Information
  • 4.10.3 Lilly Biologics and Biosimilars Production, Revenue, Price and Gross Margin
  • 4.10.4 Lilly Biologics and Biosimilars Business Performance
  • 4.10.5 SWOT Analysis
• 4.11 3sbio
• 4.12 Changchun high tech
• 4.13 CP Guojian Pharmacy
• 4.14 Biotech Pharma
• 4.15 Gelgen Biopharma
• 4.16 Sandoz
• 4.17 Teva
• 4.18 Hospira
• 4.19 Mylan
• 4.20 3sbio
• 4.21 Changchun high tech
• 4.22 CP Guojian Pharmacy
• 4.23 Biotech Pharma
• 4.24 Gelgen Biopharma

5 Competitive Landscape

• 5.1 Global Biologics and Biosimilars Production (K Units) and Market Share by Manufacturers (2014-2019)
• 5.2 Global Biologics and Biosimilars Revenue (M USD) and Market Share by Manufacturers (2014-2019)
• 5.3 Global Biologics and Biosimilars Price (USD/Unit) of Manufacturers (2014-2019)
• 5.4 Global Biologics and Biosimilars Gross Margin of Manufacturers (2014-2019)
• 5.5 Market Concentration

6 Global Biologics and Biosimilars Market Assessment by Regions

• 6.1 Global Biologics and Biosimilars Production (K Units) and Market Share by Regions (2014-2019)
• 6.2 Global Biologics and Biosimilars Revenue (M USD) and Market Share by Regions (2014-2019)
• 6.3 Global Biologics and Biosimilars Price (USD/Unit) by Regions (2014-2019)
• 6.4 Global Biologics and Biosimilars Gross Margin by Regions (2014-2019)

7 Biologics and Biosimilars Regional Analysis

• 7.1 China Biologics and Biosimilars Production, Revenue and Growth Rate (2014-2019)
• 7.2 USA Biologics and Biosimilars Production, Revenue and Growth Rate (2014-2019)
• 7.3 Europe Biologics and Biosimilars Production, Revenue and Growth Rate (2014-2019)
• 7.4 Japan Biologics and Biosimilars Production, Revenue and Growth Rate (2014-2019)
• 7.5 Korea Biologics and Biosimilars Production, Revenue and Growth Rate (2014-2019)
• 7.6 India Biologics and Biosimilars Production, Revenue and Growth Rate (2014-2019)
• 7.7 Southeast Asia Biologics and Biosimilars Production, Revenue and Growth Rate (2014-2019)
• 7.8 South America Biologics and Biosimilars Production, Revenue and Growth Rate (2014-2019)

8 Global Biologics and Biosimilars Consumption Assessment

• 8.1 Global Biologics and Biosimilars Consumption and Market Share by Regions (2014-2019)
• 8.2 Global Biologics and Biosimilars Consumption Value and Market Share by Regions (2014-2019)
• 8.3 Global Biologics and Biosimilars Average Price (USD/Unit) by Regions (2014-2019)

9 Global Biologics and Biosimilars Sales Assessment by Regions

• 9.1 Global Biologics and Biosimilars Sales and Sales Value (2014-2019)
• 9.2 China Biologics and Biosimilars Sales and Sales Value (2014-2019)
• 9.3 USA Biologics and Biosimilars Sales and Sales Value (2014-2019)
• 9.4 Europe Biologics and Biosimilars Sales and Sales Value (2014-2019)
• 9.5 Japan Biologics and Biosimilars Sales and Sales Value (2014-2019)
• 9.6 Korea Biologics and Biosimilars Sales and Sales Value (2014-2019)
• 9.7 India Biologics and Biosimilars Sales and Sales Value (2014-2019)
• 9.8 Southeast Asia Biologics and Biosimilars Sales and Sales Value (2014-2019)
• 9.9 South America Biologics and Biosimilars Sales and Sales Value (2014-2019)

10 Technology and Cost

• 10.1 Technology
• 10.2 Cost

11 Channel Analysis

• 11.1 Market Channel
• 11.2 Distributors

12 Market Forecast 2020-2025

• 12.1 Production and Revenue Forecast 2020-2025
  • 12.1.1 Global Biologics and Biosimilars Production and Revenue by Regions 2020-2025
  • 12.1.2 China Biologics and Biosimilars Production, Revenue and Growth Rate 2020-2025
  • 12.1.3 USA Biologics and Biosimilars Production, Revenue and Growth Rate 2020-2025
  • 12.1.4 Europe Biologics and Biosimilars Production, Revenue and Growth Rate 2020-2025
  • 12.1.5 Japan Biologics and Biosimilars Production, Revenue and Growth Rate 2020-2025
  • 12.1.6 Korea Biologics and Biosimilars Production, Revenue and Growth Rate 2020-2025
  • 12.1.7 India Biologics and Biosimilars Production, Revenue and Growth Rate 2020-2025
  • 12.1.8 Southeast Asia Biologics and Biosimilars Production, Revenue and Growth Rate 2020-2025
  • 12.1.9 South America Biologics and Biosimilars Production, Revenue and Growth Rate 2020-2025
• 12.2 Sales and Sales Value Forecast 2020-2025
  • 12.2.1 Global Biologics and Biosimilars Consumption and Consumption Calue by Regions 2020-2025
  • 12.2.2 Global Biologics and Biosimilars Sales and Sales Value Forecast 2020-2025
  • 12.2.3 China Biologics and Biosimilars Sales, Sales Value and Growth Rate 2020-2025
  • 12.2.4 USA Biologics and Biosimilars Sales and Sales Value Forecast 2020-2025
  • 12.2.5 Europe Biologics and Biosimilars Sales and Sales Value Forecast 2020-2025
  • 12.2.6 Japan Biologics and Biosimilars Sales and Sales Value Forecast 2020-2025
  • 12.2.7 Korea Biologics and Biosimilars Sales and Sales Value Forecast 2020-2025
  • 12.2.8 India Biologics and Biosimilars Sales and Sales Value Forecast 2020-2025
  • 12.2.9 Southeast Asia Biologics and Biosimilars Sales and Sales Value Forecast 2020-2025
  • 12.2.10 South America Biologics and Biosimilars Sales and Sales Value Forecast 2020-2025
• 12.3 Global Biologics and Biosimilars Production and Revenue Forecast by Type 2020-2025
  • 12.3.1 Overall Market Performance
  • 12.3.2 Classification by Technology
  • 12.3.3 Classification by Types
  • 12.3.4 Classification by Use
  • 12.3.5 Classification by Services
• 12.4 Global Biologics and Biosimilars Sales Forecast by Application 2020-2025
  • 12.4.1 Overall Market Performance
  • 12.4.2 Tumor
  • 12.4.3 Diabetes
  • 12.4.4 Cardiovascular
  • 12.4.5 Hemophilia
  • 12.4.6 Other
• 12.5 Global Biologics and Biosimilars Price and Gross Margin Forecast
  • 13.5.1 Global Biologics and Biosimilars Averages Price Development Trend Forecast 2020-2025
  • 13.5.2 Global Biologics and Biosimilars Gross Margin Development Trend Forecast 2020-2025

13 Conclusion